The safety and efficacy of hepalatide (L47) treatment combined with pegylated interferon-alpha 2a in patients with chronic hepatitis B: the preliminary data froma double-blind, RCT phase II trial

Authors
Category Primary study
ConferenceJournal of Hepatology
Year 2023
This article has no abstract
Epistemonikos ID: c6be74bb74a2fc3fcea9cf1909579f430a848dc6
First added on: Apr 28, 2026